Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Alpharma Forms Vancomycin JV with Zhejiang Hisun

publication date: Jun 16, 2008

Alpharma, a large generic drugs company, will amend its Vancomycin production agreement with Zhejiang Hisun Pharmaceutical Co., Ltd. The two companies will establish a 51%-49% joint venture that will manufacture Vancomycin, with Alpharma being the majority partner. Under an agreement signed two years ago, Alpharma was supposed to build a Vancomycin manufacturing facility on Zhejiang Hisun’s land, using the latter company’s manufacturing technology. More  details...

Stock Symbols: (NYSE: ALO) (SHSE: 600267)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital